Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Gliomas are the most common primary brain tumors, exhibiting significant phenotypic variability even within the same grade. Identifying glioma subtypes through non-invasive methods could improve patient management. METHODS: In this study, we applied hierarchical multi-kernel learning to identify glioma phenotypic subtypes using MRI data (T1CE and T2FLAIR) from the First Hospital of Sha...
Doxorubicin (Dox)-induced cardiotoxicity remains a critical barrier to optimizing breast cancer (BC) treatment, highlighting the urgent need to dissect its toxicological mechanisms and develop toxicity-mitigating combination strategies; here, we address this gap by integrating network toxicology, molecular dynamics simulations, bioinformatics, and machine learning to unravel how tanshinone IIA (Ta...
Re-excision rates remain high for early-stage breast cancer patients due to challenges in margin delineation during surgery, such as poorly defined tu...
The epidermal growth factor receptor (EGFR) is a key target in cancer therapy, mainly in non-small cell lung cancer (NSCLC). Though, the efficacy of E...
OBJECTIVE: Dosiomics and radiomics elaborate the low-and high-order features extracted from images to predict clinical outcomes. Whole-brain radiother...
Minimal residual disease (MRD) refers to the presence of residual cancer cells or tumor-derived fragments that persist after treatment and remain unde...
Lung squamous cell carcinoma (LUSC) has a poor prognosis due to the lack of effective targeted therapies, and its incidence has increased dramatically...
BACKGROUND: Lymph node (LN) metastasis is a well-established independent prognostic factor in head and neck squamous cell carcinoma (HNSCC). Formation...
INTRODUCTION: While current blood-based biomarkers for Alzheimer's disease (AD) are effective for determining amyloid beta (Aβ) pathology positivity/n...
Vancomycin (VAN) remains the first-line treatment for methicillin-resistant, multidrug-resistant gram-positive bacterial infections, even among cancer...
Recent advancements in cancer immunotherapy have transformed clinical oncology, with monoclonal antibodies (mAbs), immune checkpoint inhibitors, adopt...
Hepatocellular carcinoma (HCC) represents an extremely complex and heterogeneous malignant tumor. Protein palmitoylation, a highly conserved and pivot...
BACKGROUND: Accurate assessment of mortality, bleeding, and atherothrombotic risk in patients with cancer and acute coronary syndrome could inform nov...
R-loops are dynamic nucleic acid structures implicated in genome regulation and instability, yet their contributions to the tumor microenvironment (TM...
Ribonucleic acid (RNA) modifications, once viewed as static structural features, are now recognized as dynamic regulators of the 'epitranscriptome' th...
BACKGROUND: Uveal melanoma (UM) is a rare cancer with an estimated annual incidence of 6 incidences per million people. About half of UM patients deve...
Primary liver cancer, mainly hepatocellular carcinoma and intrahepatic cholangiocarcinoma, remains a leading cause of cancer mortality worldwide. Earl...
BACKGROUND AND PURPOSE: Deep learning (DL) reconstruction methods have shown promise in accelerating 2D MRI sequences but have yet to be extensively v...
Drug repositioning aims to identify new indications for existing drugs, offering a cost-effective and time-efficient strategy for therapeutic developm...